• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国男孩中具有新表型和基因型的TMEM199-先天性糖基化障碍

TMEM199-Congenital Disorder of Glycosylation With Novel Phenotype and Genotype in a Chinese Boy.

作者信息

Fang Yuan, Abuduxikuer Kuerbanjiang, Wang Yi-Zhen, Li Shao-Mei, Chen Lian, Wang Jian-She

机构信息

Department of Pathology, Anhui Provincial Children's Hospital, Hefei, China.

Department of Hepatology, Children's Hospital of Fudan University, Shanghai, China.

出版信息

Front Genet. 2022 Mar 24;13:833495. doi: 10.3389/fgene.2022.833495. eCollection 2022.

DOI:10.3389/fgene.2022.833495
PMID:35401690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8988039/
Abstract

TMEM199-congenital disorder of glycosylation (TMEM199-CDG) is a rare autosomal recessive inherited disease characterized by chronically elevated serum transaminase, decreased serum ceruloplasmin, steatosis and/or fibrosis, mutation, reduced level of TMEM199 protein, and abnormal protein glycosylation. The information of a Chinese patient with TMEM199-CDG in the Children's Hospital of Fudan University was reviewed. The patient's clinical, pathological, and molecular features were obtained by clinical data study, liver biopsy, immunohistochemistry, and molecular genetic analysis. A 4-year-old Chinese boy presented with hypertransaminasemia, hypercholesterolemia, elevated alkaline phosphatase, decreased serum ceruloplasmin and serum copper level, and coagulopathy since birth. To the best of our knowledge, novel findings included strabismus, cirrhosis by liver biopsy, reduced expression of TMEM199 by immunohistochemistry, and a frameshift variant of c.128delA/p.Lys43Argfs*25 in the gene. This case added to the phenotypic and genotypic spectrum of TMEM199-CDG.

摘要

跨膜蛋白199相关先天性糖基化障碍(TMEM199-CDG)是一种罕见的常染色体隐性遗传病,其特征为血清转氨酶持续升高、血清铜蓝蛋白降低、脂肪变性和/或纤维化、基因突变、TMEM199蛋白水平降低以及蛋白糖基化异常。对复旦大学附属儿科医院一名TMEM199-CDG中国患者的信息进行了回顾。通过临床资料研究、肝活检、免疫组织化学和分子遗传学分析获得了该患者的临床、病理和分子特征。一名4岁中国男孩自出生以来就出现高转氨酶血症、高胆固醇血症、碱性磷酸酶升高、血清铜蓝蛋白和血清铜水平降低以及凝血功能障碍。据我们所知,新发现包括斜视、肝活检显示肝硬化、免疫组织化学检测显示TMEM199表达降低以及该基因存在c.128delA/p.Lys43Argfs*25移码变异。该病例丰富了TMEM199-CDG的表型和基因型谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8988039/aac6240988e5/fgene-13-833495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8988039/9d1dfeda0020/fgene-13-833495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8988039/aac6240988e5/fgene-13-833495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8988039/9d1dfeda0020/fgene-13-833495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8988039/aac6240988e5/fgene-13-833495-g002.jpg

相似文献

1
TMEM199-Congenital Disorder of Glycosylation With Novel Phenotype and Genotype in a Chinese Boy.中国男孩中具有新表型和基因型的TMEM199-先天性糖基化障碍
Front Genet. 2022 Mar 24;13:833495. doi: 10.3389/fgene.2022.833495. eCollection 2022.
2
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation.三例 TMEM199-CDG 未报告病例,这是一种罕见的遗传性肝脏疾病,伴有异常糖基化。
Orphanet J Rare Dis. 2018 Jan 10;13(1):4. doi: 10.1186/s13023-017-0757-3.
3
Higher frequency of TMEM199-CDG in the southern mediterranean area is associated with c.92G>C (p.Arg31Pro) mutation.在南地中海地区,TMEM199-CDG 的发病率较高,与 c.92G>C(p.Arg31Pro)突变有关。
Eur J Med Genet. 2023 Mar;66(3):104709. doi: 10.1016/j.ejmg.2023.104709. Epub 2023 Jan 24.
4
TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation.跨膜蛋白199缺陷是一种高尔基体稳态紊乱疾病,其特征为转氨酶、碱性磷酸酶和胆固醇升高以及糖基化异常。
Am J Hum Genet. 2016 Feb 4;98(2):322-30. doi: 10.1016/j.ajhg.2015.12.011. Epub 2016 Jan 28.
5
CCDC115-CDG: A new rare and misleading inherited cause of liver disease.CCDC115-CDG:一种新的罕见且易误诊的肝脏疾病遗传性病因。
Mol Genet Metab. 2018 Jul;124(3):228-235. doi: 10.1016/j.ymgme.2018.05.002. Epub 2018 May 9.
6
Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115.缺陷性脂滴-溶酶体相互作用导致脂肪性肝病,这可由 TMEM199 和 CCDC115 中的人类突变得到证明。
Cell Mol Gastroenterol Hepatol. 2022;13(2):583-597. doi: 10.1016/j.jcmgh.2021.09.013. Epub 2021 Oct 7.
7
What is new in CDG?CDG 有哪些新进展?
J Inherit Metab Dis. 2017 Jul;40(4):569-586. doi: 10.1007/s10545-017-0050-6. Epub 2017 May 8.
8
Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature.肝脏在先天性糖基化障碍(CDG)中的表现。文献系统综述
J Inherit Metab Dis. 2017 Mar;40(2):195-207. doi: 10.1007/s10545-016-0012-4. Epub 2017 Jan 20.
9
MAN1B1-CDG: novel patients and novel variant.甘露糖-1-磷酸尿苷酰转移酶缺陷症 1B 型:新病例和新变异。
J Pediatr Endocrinol Metab. 2021 Jun 24;34(9):1207-1209. doi: 10.1515/jpem-2021-0038. Print 2021 Sep 27.
10
Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.39 例先天性糖基化障碍患者的肝脏表现:明确肝脏损伤的特征并提出随访建议。
Orphanet J Rare Dis. 2021 Jan 7;16(1):20. doi: 10.1186/s13023-020-01630-2.

引用本文的文献

1
Nuclear transmembrane protein 199 promotes immune escapes by up-regulating programmed death ligand 1.核跨膜蛋白199通过上调程序性死亡配体1促进免疫逃逸。
iScience. 2024 Nov 28;27(12):111485. doi: 10.1016/j.isci.2024.111485. eCollection 2024 Dec 20.
2
Expanding the phenotype and metabolic basis of ATP6AP2-congenital disorder of glycosylation in a Chinese patient with a novel variant c.185G>A (p.Gly62Glu).在中国一名携带新型变异c.185G>A(p.Gly62Glu)的患者中扩展ATP6AP2先天性糖基化障碍的表型和代谢基础。
Front Genet. 2023 Nov 22;14:1264237. doi: 10.3389/fgene.2023.1264237. eCollection 2023.
3
Hypomorphic variants of SEL1L-HRD1 ER-associated degradation are associated with neurodevelopmental disorders.

本文引用的文献

1
Contribution of intragenic deletions to mutation spectrum in Chinese patients with Wilson's disease and possible mechanism underlying ATP7B gross deletions.基因内缺失对中国 Wilson 病患者突变谱的贡献及 ATP7B 大片段缺失的潜在机制。
Parkinsonism Relat Disord. 2019 May;62:128-133. doi: 10.1016/j.parkreldis.2019.01.001. Epub 2019 Jan 2.
2
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation.三例 TMEM199-CDG 未报告病例,这是一种罕见的遗传性肝脏疾病,伴有异常糖基化。
Orphanet J Rare Dis. 2018 Jan 10;13(1):4. doi: 10.1186/s13023-017-0757-3.
3
The vacuolar-ATPase complex and assembly factors, TMEM199 and CCDC115, control HIF1α prolyl hydroxylation by regulating cellular iron levels.
SEL1L-HRD1 内质网相关降解的功能减弱变体与神经发育障碍有关。
J Clin Invest. 2024 Jan 16;134(2):e170054. doi: 10.1172/JCI170054.
液泡型ATP酶复合物及组装因子TMEM199和CCDC115通过调节细胞铁水平来控制低氧诱导因子1α(HIF1α)脯氨酰羟化。
Elife. 2017 Mar 15;6:e22693. doi: 10.7554/eLife.22693.
4
Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature.肝脏在先天性糖基化障碍(CDG)中的表现。文献系统综述
J Inherit Metab Dis. 2017 Mar;40(2):195-207. doi: 10.1007/s10545-016-0012-4. Epub 2017 Jan 20.
5
TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation.跨膜蛋白199缺陷是一种高尔基体稳态紊乱疾病,其特征为转氨酶、碱性磷酸酶和胆固醇升高以及糖基化异常。
Am J Hum Genet. 2016 Feb 4;98(2):322-30. doi: 10.1016/j.ajhg.2015.12.011. Epub 2016 Jan 28.
6
Congenital disorders of glycosylation.先天性糖基化障碍
Handb Clin Neurol. 2013;113:1737-43. doi: 10.1016/B978-0-444-59565-2.00044-7.
7
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation.四名儿童的隐源性肝病:一种新型糖基化先天性疾病。
Pediatr Res. 2006 Feb;59(2):293-8. doi: 10.1203/01.pdr.0000196378.30165.26.
8
Characterizing glycosylation pathways.表征糖基化途径。
Genome Biol. 2001;2(5):REVIEWS0004. doi: 10.1186/gb-2001-2-5-reviews0004. Epub 2001 May 1.
9
Classification of chronic viral hepatitis: a need for reassessment.慢性病毒性肝炎的分类:重新评估的必要性。
J Hepatol. 1991 Nov;13(3):372-4. doi: 10.1016/0168-8278(91)90084-o.